Bioventus (BVS) Competitors

Alpha Tau Medical (NASDAQ:DRTSW) and Bioventus (NASDAQ:BVS) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Does the media prefer DRTSW or BVS?

In the previous week, Bioventus had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 1 mentions for Bioventus and 0 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.89 beat Bioventus' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Alpha Tau Medical	Very Positive
Bioventus	Neutral

Which has stronger valuation & earnings, DRTSW or BVS?

Alpha Tau Medical has higher earnings, but lower revenue than Bioventus.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
Bioventus	$573.28M	0.90	-$33.54M	-$0.48	-13.04

Is DRTSW or BVS more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to Bioventus' net margin of -5.57%. Bioventus' return on equity of 21.47% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	N/A	N/A
Bioventus	-5.57%	21.47%	5.38%

Do insiders and institutionals hold more shares of DRTSW or BVS?

62.9% of Bioventus shares are owned by institutional investors. 33.0% of Bioventus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Bioventus beats Alpha Tau Medical on 6 of the 8 factors compared between the two stocks.